Stock data
Pasithea Therapeutics Corp. (KTTA)
Pasithea Therapeutics Corp. (KTTA) reported net income of -US$20.43M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$20.86M | -US$20.43M | — |
| 2024 | — | — | -US$14.25M | -US$13.90M | — |
| 2023 | — | — | -US$15.98M | -US$15.96M | — |
| 2022 | US$0.49M | — | -US$12.59M | -US$13.94M | — |
| 2021 | US$0.02M | -US$0.00M | -US$4.51M | -US$2.17M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$5.27M | — |
| 2026-03-31 | — | -US$2.87M | — |
| 2025-12-31 | — | -US$10.11M | — |
| 2025-09-30 | — | -US$3.04M | — |
| 2025-06-30 | — | -US$3.72M | — |
| 2025-03-31 | — | -US$3.56M | — |
| 2024-12-31 | — | -US$3.18M | — |
| 2024-09-30 | — | -US$3.00M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.